New appointments round-up
profile personnel changes at Source One Global Partners, Kyowa
Hakko USA and Herbalife.
James Roza has joined SourceOne Global Partners as vice president business development, technology and science. Roza's previous industry experience includes a spell at NOW Foods, where he is credited with aiding the company's expansion. In his new role he will be responsible for evaluating new business opportunities and providing expertise on scientific, technical and global regulatory affairs.
Chikakuni Kotani has been named as the new vice president for sales and marketing for health ingredients manufacturer Kyowa Hakko USA. Kotani's career with Kyowa Hakko dates back over 20 years, during which time his responsibilities have included the fine chemicals division.
Michael Walsh has been appointed chairman of food group Glanbia and the Glanbia Co-operative Society, replacing Tom Corcoran who has retired. Walsh is replaced in his previous position as vice-chairman by Victor Quinlan.
Herbalife has tapped Unibanco director of consumer lines Marcelo Zalcberg to become its new operations director for Herbalife Brazil. In his new role at the global network marketing company, Zalcberg will be responsible for distributor operations, logistics, regulatory affairs and local manufacturing.
PhytoMedical Technologies, research-based biopharmaceutical company that aims to identify, develop and commercialize plant derived pharmaceutical and nutraceutical compounds, has bolstered its scientific research team with the addition of Dr Heping Cao and Dr John Striffler. The two new recruits will investigate the beneficial effects of cinnamon on insulin and diabetes.
Theramedix is to benefit from the expertise of Dr Tara Levy, a naturopathic doctor and strong advocate of nutrition enzyme therapy. Levy, who believes that proper formulations have been missing from the professional health care market, joins the niche nutraceuticals company's advisory board.
Biotechnology company Sciona has named Roy Whitfield to its board of directors and appointed him chairman of the company's Science and Business Advisory Board. Whitfield's brief is to focus on public policy, intellectual property and business development issues.
